Oppenheimer initiated coverage on shares of Sensei Biotherapeutics (NASDAQ:FTH – Get Free Report) in a note issued to investors on Tuesday,Benzinga reports. The firm set an “outperform” rating and a $60.00 price target on the stock. Oppenheimer’s price target suggests a potential upside of 105.20% from the stock’s previous close. A number of other equities […]

Equities research analysts at Maxim Group began coverage on shares of Rein Therapeutics (NASDAQ:RNTX – Get Free Report) in a research note issued to investors on Monday,Benzinga reports. The firm set a “buy” rating and a $4.00 price target on the stock. Maxim Group’s price target would suggest a potential upside of 365.12% from the […]